CW vs WST · P/E 43, rev $1.84B vs P/E 35, rev $1.72B
Curtiss-Wright Corporation (CW) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Curtiss-Wright Corporation (CW) is a aerospace & defense company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported CW revenue for 2026-06-30 was $1.84B. Net income was $279.4M. CW currently screens at market cap $18.20B and trailing P/E 42.9.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
CW currently screens at market cap $18.20B and trailing P/E 42.9. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the CW and WST stock pages for the full models.
Not investment advice.